6533b851fe1ef96bd12aa229
RESEARCH PRODUCT
The potential of antimicrobial peptides isolated from freshwater crayfish species in new drug development: A review
Mirella VazzanaVincenzo ArizzaGiampaolo BaroneDomenico SchillaciAlan DeidunDiletta PunginelliManuela Maurosubject
Innate immune systembiologymedicine.drug_classImmunologyAntibioticsAntimicrobial peptidesFresh WaterContext (language use)Pathogenic bacteriaAstacoideaGram-Positive Bacteriabiology.organism_classificationCrayfishAntimicrobialmedicine.disease_causeAnti-Bacterial AgentsMicrobiologyGram-Negative BacteriamedicineAnimalsAMP Antibiotic Bioactive compound Crustacea Invertebrate Pathogenic bacteriaAntimicrobial PeptidesBacteriaAntimicrobial Cationic PeptidesDevelopmental Biologydescription
Abstract The much-publicised increased resistance of pathogenic bacteria to conventional antibiotics has focused research effort on the characterization of new antimicrobial drugs. In this context, antimicrobial peptides (AMPs) extracted from animals are considered a promising alternative to conventional antibiotics. In recent years, freshwater crayfish species have emerged as an important source of bioactive compounds. In fact, these invertebrates rely on an innate immune system based on cellular responses and on the production of important effectors in the haemolymph, such as AMPs, which are produced and stored in granules in haemocytes and released after stimulation. These effectors are active against both Gram-positive and Gram-negative bacteria. In this review, we summarise the recent progress on AMPs isolated from the several species of freshwater crayfish and their prospects for future pharmaceutical applications to combat infectious agents.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-02-10 |